
As rotavirus vaccine coverage increased from 2009 to 2011, diarrhea-associated healthcare utilization and costs continued the decline that began after the pentavalent rotavirus vaccine (RV5) and the monovalent vaccine (RV1) joined the recommended vaccine list in 2006 and 2008, respectively.
